Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Xeris Pharmaceuticals, Inc.

NASDAQ: XERSHealthcare / Biotechnology / USA
9.84-0.1400-1.40%Vol 229 8921Y Perf -51.71%
Feb 20th, 2019 16:00
BID9.84 ASK9.95
Open9.94 Previous Close9.98
Pre-Market- After-Trading-
 - -%  - -%
Target Price
25.75 
Analyst Rating
— — 0.00
Potencial %
161.69 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)206 
Earnings Rating
Price Range Ratio 52wk %
3.36 
Earnings Date
-

Today's Price Range

9.549.97

 

52wk Range

9.2127.98

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-42.12%
3 Months
-52.21%
6 Months
-60.37%
1 Year
-51.71%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
XERS9.84-0.1400-1.40
AAPL172.031.10000.64
GOOG1 113.80-4.7600-0.43
MSFT107.15-1.0200-0.94
XOM78.530.30000.38
WFC49.810.43000.87
JNJ136.350.66000.49
FB162.560.27000.17
GE10.10-0.0300-0.30
JPM105.690.51000.48
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
16.20
Current Ratio
16.50
Long Term Debt to Total Capital
0.25
Total Debt to Equity
0.33
Interest Coverage
-31.70
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
98.00
EBIT Margin
-2 220.40
EBITDA Margin
-2 211.00
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.53
PS Ratios
115.50
Price to Cash Flow
-
Price to Free Cash Flow
-6.10
Cash Flow Per Share
-2.27
Price to Tangible Book
2.53
Book Value per Share
4.56
Enterprise Value (in ths.)
141 407
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-51.31
Return on Assets (5Y Avg)
-
ROA last 12 Months
-35.47
Return on Capital (5Y Avg)
-
ROC last 12 Months
-38.02
Return on invested Capital Q
-11.40
Return on invested Capital Y
-
Assets Turnover
0.00
Receivables Turnover
1.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
1 664
Revenue per Share
0.08
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume229 892
Shares Outstanding (in ths.)20 893
Trades Count1 262
Dollar Volume1 985 406
Avg. Volume178 095
Avg. Weekly Volume909 504
Avg. Monthly Volume279 566
Avg. Quarterly Volume125 834

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News